#$%^&*AU2018203081A120180524.pdf#####ABSTRACT The invention provides antibodies that specifically bind to Kallidin or des-Arg1O-Kallidin. The invention also provides pharmaceutical compositions, as well as nucleic acids encoding antiKallidin or des-ArglO-Kallidin antibodies, recombinant expression vectors and host cells for making such antibodies, or fragments thereof. Methods of using antibodies of the invention to modulate Kallidin or des-ArglO-Kallidin activity or detect Kallidin or des-ArglO-Kallidin or, either in vitro or in vivo, are also provided by the invention. The invention further provides methods of making antibodies that specifically bind to des-Argg- Bradykinin and des-Argio-Kallidin-like peptide. 20035827vl 1
